Multiple myeloma (MM) is a highly heterogeneous and incurable disease. Inflammation plays a vital role in cancer genesis and progression.

RDW is an erythrocyte index that increase in multiple myeloma, in which it appears to have an important role in predicting outcome.

High levels of physical activity are associated with reduced risk of the blood cancer multiple myeloma (MM).

Neurolymphomatosis (NL) describes an infiltration of cranial and peripheral nerves by lymphoma cells, most frequently in non-Hodgkin B-cell lymphoma...

This study investigates the potential value of metabolic and texture features, extracted from baseline 18F-FDG Positron Emission Tomography/Computed...

The objective of the present study was to investigate oral health status, oral health related quality of life, and identify risk factors associated...

Multiple myeloma (MM) is an incurable B-cell malignancy, but with the emergence of immunotherapy, a potential cure is hopeful.

Multiple myeloma (MM) is a cancer of plasma cells. Normal (NL) cells are considered to pass through a precancerous state, such as monoclonal...

A retrospective study involving review of 71 medical records of patients diagnosed with Hodgkin's Lymphoma between February 2012 and January 2016 was...

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and...

To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin’s Lymphoma treated at the...

Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation...